National Health Investors Inc. (NYSE:NHI) – Equities research analysts at KeyCorp decreased their FY2016 earnings estimates for shares of National Health Investors in a research note issued on Wednesday. KeyCorp analyst J. Sadler now forecasts that the firm will post earnings of $4.87 per share for the year, down from their previous estimate of $4.92. KeyCorp also issued estimates for National Health Investors’ Q4 2016 earnings at $1.27 EPS, Q1 2017 earnings at $1.27 EPS and Q2 2017 earnings at $1.29 EPS.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Monday, November 7th. The real estate investment trust reported $1.23 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.25 by $0.02. National Health Investors had a return on equity of 14.12% and a net margin of 68.03%. The business had revenue of $63.30 million for the quarter, compared to analyst estimates of $62.39 million. During the same quarter in the previous year, the business posted $1.07 earnings per share. The business’s revenue was up 8.6% on a year-over-year basis.

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Several other brokerages have also issued reports on NHI. Cantor Fitzgerald reiterated a “hold” rating on shares of National Health Investors in a research report on Friday, September 9th. Wells Fargo & Co. reiterated a “hold” rating on shares of National Health Investors in a research report on Sunday, September 4th. Zacks Investment Research upgraded shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 11th. Mizuho upped their target price on shares of National Health Investors from $66.00 to $77.00 and gave the stock a “neutral” rating in a research report on Monday, August 8th. Finally, Stephens began coverage on shares of National Health Investors in a research report on Wednesday, September 14th. They issued an “overweight” rating and a $84.00 target price for the company. Six analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $75.33.

Shares of National Health Investors (NYSE:NHI) opened at 68.10 on Friday. The firm has a market capitalization of $2.71 billion, a P/E ratio of 15.96 and a beta of 0.66. National Health Investors has a one year low of $54.51 and a one year high of $82.53. The firm’s 50-day moving average price is $75.71 and its 200-day moving average price is $75.07.

Hedge funds have recently bought and sold shares of the company. Societe Generale acquired a new stake in National Health Investors during the second quarter valued at $103,000. Creative Planning increased its position in shares of National Health Investors by 2.6% in the second quarter. Creative Planning now owns 1,390 shares of the real estate investment trust’s stock valued at $104,000 after buying an additional 35 shares during the period. Bronfman E.L. Rothschild L.P. purchased a new position in shares of National Health Investors during the third quarter valued at approximately $118,000. BNP Paribas Arbitrage SA increased its position in shares of National Health Investors by 6,303.6% in the second quarter. BNP Paribas Arbitrage SA now owns 1,793 shares of the real estate investment trust’s stock valued at $135,000 after buying an additional 1,765 shares during the period. Finally, BlackRock Japan Co. Ltd increased its position in shares of National Health Investors by 5.7% in the third quarter. BlackRock Japan Co. Ltd now owns 1,913 shares of the real estate investment trust’s stock valued at $150,000 after buying an additional 104 shares during the period. 70.50% of the stock is owned by institutional investors and hedge funds.

In other National Health Investors news, Director Robert A. Mccabe, Jr. sold 800 shares of the business’s stock in a transaction on Tuesday, August 30th. The shares were sold at an average price of $80.29, for a total value of $64,232.00. Following the completion of the sale, the director now directly owns 10,021 shares of the company’s stock, valued at $804,586.09. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 5.74% of the stock is currently owned by company insiders.

About National Health Investors

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

5 Day Chart for NYSE:NHI

Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.